Medtronic Bets On Future Mazor Robotics Spine Surgery Systems
Medtronic is putting its sales and marketing power behind Israel-based Mazor Robotics with new commercial agreement and investment deals, both announced May 18.
You may also be interested in...
Zimmer Biomet will gain through a $130m deal a spine-surgery robot that may be able to compete in the emerging minimally invasive spine surgery segment. The technology will also complement Zimmer Biomet’s other recent acquisition in spine surgery devices.
Zelnecirnon (RPT193), in Phase IIb for atopic dermatitis and Phase IIa for asthma, may not have caused the case of liver failure cited in the hold but the pause may impede a crucial data readout.
Given the enthusiasm for the new advisory committee within the rare disease community, the need for an extended deadline is somewhat surprising. FDA has not yet determined when the chair and members of the new panel will be named.